![]() |
市场调查报告书
商品编码
1847180
美国麻醉、呼吸和睡眠管理设备市场:市场规模、份额和趋势分析(2025-2031 年)Anesthesia, Respiratory & Sleep Management Devices Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Anesthesia Delivery Units (ADUs), Ventilators, Nebulizers, and 8 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年,美国麻醉、呼吸和睡眠管理设备市场价值约70亿美元。预计在预测期内,该市场将接近90亿美元。
本报告涵盖麻醉输送装置、麻醉监控器、麻醉资讯管理系统、麻醉抛弃式、人工呼吸器、雾化器、呼吸抛弃式、氧气疗法设备、阻塞型睡眠呼吸中止症中止症治疗设备、睡眠诊断设备和体外膜氧气疗法(ECMO)系统。
定量研究对象包括销售量、平均售价、市场规模、成长率和企业市场占有率。
定性分析包括市场驱动因素和限制因素、併购、产品系列、相关召回以及在医院、门诊手术中心和居家医疗的竞争定位。
市场概览
人口结构变化和技术的普及持续影响着美国对 ARS 设备的需求。人口老化和肥胖率上升加剧了呼吸系统疾病和睡眠呼吸中止症的负担,同时也增加了依赖安全麻醉护理的外科手术数量。
医疗系统正在对麻醉和监护设备进行现代化改造,使其与电子健康记录系统对接,这导致设备更换时间和采购优先顺序发生变化。在呼吸和睡眠治疗领域,许多设备正从固定式转向可携式,以提高患者的舒适度、依从性和院外护理能力。
随着医疗保健领域标准化程度的不断提高,能够将可靠的硬体与简单的工作流程、数据连接和服务计划相结合的供应商将占据有利地位。
市场驱动因素
人口结构压力。婴儿潮世代如今已占美国人口的最大比例。据估计,40%的美国人患有肥胖症。这两个趋势将增加手术中麻醉的需求,以及需要呼吸支持和睡眠呼吸中止症治疗的患者人数。
转向居家和门诊护理。可携带式氧气设备、家用人工呼吸器、微型雾化器和正压呼吸器将护理范围扩展到了家庭。门诊手术中心采用适合短期住院流程的麻醉监测和资讯系统。
科技日新月异。最新的麻醉机和人工呼吸器采用电子控制,操作精准便捷。睡眠治疗和诊断设备不断增加功能,以提高舒适度和患者依从性。行动应用程式和远端监控功能则为指导、数据共用和后续随访提供了支援。
电子病历整合和自动化。医院程序倾向于支援自动化编程和文件记录的设备,这推动了老旧麻醉机和监视器被可连接到排班和记录系统的系统所取代。
公众意识和检测。儘管人们对睡眠呼吸中止症的认识正在提高,但许多重症病例仍未被诊断出来。支持居家睡眠检测的政策可以提高诊断率,并使更多患者接受治疗。
市场限制
高昂的购置和维护成本。麻醉机、人工呼吸器和资讯系统需要前期投资以及持续的训练和服务。小型医院和一些公共医疗机构预算有限,这可能会延迟更换。
患者依从性差。睡眠呼吸中止症和氧气治疗的长期治疗需要持续使用。不适和不便会降低患者的依从性,并减少实际用药量与临床需求之间的差距。
集团采购竞标定价和竞标。集团采购组织压缩价格分布。耐用医疗设备竞标计画适用于睡眠和氧气疗法,导致报销减少,并影响设备价格和医疗服务提供者的行为。
报销压力。家用氧气及相关服务的报销额度降低,导致供应商净利率下降。政策变化也导致部分地区的氧气供应商数量减少。
缺乏熟练人员。呼吸治疗师、麻醉师和睡眠技师的短缺限制了服务扩张的速度,尤其是在大都会圈。
目标市场和数据范围
量化指标:市场规模、市场占有率、市场预测、成长率、销售量、平均售价。
定性内容:市场成长趋势、市场限制、主要竞争对手的竞争分析和 SWOT 分析、併购、公司简介和产品系列、FDA 召回(如适用)、颠覆性技术、影响需求的疾病概况。
时限:基准年 2024 年,预测年 2025-2031 年,历史资料 2021-2023 年。
资料来源:对行业领导者的直接访谈、政府医生和程序资料、监管资料库、私人医院资料、进出口资料、iData Research 内部资料库。
方法论收入模型采用单位乘以平均售价,并针对医院和家庭环境的安装基础、使用率和政策影响检验。
目标市场及区隔
麻醉输送单元(ADU)市场
透过设置地点:医院手术室、其他医院套房和门诊手术中心。
麻醉监控器市场
依地点划分:医院监视器、门诊手术中心监视器。
麻醉资讯管理系统(AIMS)市场
依地点划分:医院、门诊手术中心。
抛弃式麻醉剂市场
依设备类型分类:麻醉管路、麻醉面罩、气管插管、喉罩。
人工呼吸器市场
按设备类型划分:急性护理、亚急性护理、居家医疗、新生儿护理、非侵入性护理和紧急运输。
雾化器市场
依设备类型:压缩机或喷射式、振动式。
抛弃式呼吸防护设备市场
依设备类型分类:氧气鼻导管、氧气罩、气切管、人工呼吸器、诱发性肺量计、热湿交换器。
氧气疗法市场
依设备类型划分:氧气浓缩机、氧气输送装置、医用铝製氧气瓶、居家医疗氧气稳压器、氧气保护器和高流量鼻腔治疗装置。
阻塞型睡眠呼吸中止症症治疗市场
依设备类型:正压呼吸器、睡眠治疗介面。
睡眠诊断设备市场
依设备类型:I 型、II 型、III 型、IV 型。
体外膜氧气疗法(ECMO)市场
依设备类型:机器、抛弃式。
竞争分析
瑞思迈在阻塞型睡眠呼吸中止症领域的优势使其在2024年引领了整个ARS市场。该公司在睡眠诊断领域也占有一席之地,并在人工呼吸器和呼吸抛弃式占据了相当可观的份额。
飞利浦在麻醉监控器排名第二。该公司先前在人工呼吸器、阻塞性睡眠呼吸中止症、睡眠诊断和氧气疗法处于领先地位,但由于召回事件而退出了美国这些细分市场。
CAIRE 是一家领先的氧气浓缩机公司,拥有可携式和可移动式氧气浓缩器产品组合,并计划在 2025 年推出固定式产品。
其他竞争对手正进军麻醉、呼吸器、睡眠呼吸器、氧气疗法和抛弃式领域。产品组合的兼容性、服务网路和资料整合对于长期市场定位至关重要。
科技与临床趋势
可携式易用的设备。制氧机和雾化器更轻、更简单。 PAP系统和介面可提高舒适度,进而提高治疗顺从性。
数位化连接麻醉:现代麻醉单元和监视器的选择是基于与 EMR 工作流程的易于整合性。
准备情况和现有设备。新冠疫情提高了人们对突波能力和感染控制的认识。虽然资本市场在最初的激增后已经调整,但在许多项目中,抛弃式的使用量仍然高于疫情前的水平。
居家睡眠检测。政策支持居家检测将扩大检测范围,使更多患者能够接受治疗。
治疗地点
适用范围涵盖医院、门诊手术中心、相关医生诊所和居家医疗机构。护理地点的转变会影响定价、产品选择、物流和服务模式。供应商透过客製化套件、远端监控选项和简化的患者介面系统来应对这些差异。
地区
本报告涵盖美国。
美国麻醉、呼吸和睡眠管理设备市场中规模最大、成长最快的机会是什么?到 2031 年,哪些类别将为价值创造做出最大贡献?
ARS 设备市场与美国更广泛的经济和医疗保健提供者运作(包括人员配备、报销和临床工作流程的数位转型)有何关係?
未来哪些因素将影响市场格局,包括人口老化、肥胖、门诊病人转型、电子病历整合、居家睡眠测试和紧急准备计画?
政策和报销如何影响价格和取得途径,包括集团采购组织、耐久财竞标计画以及家庭氧气疗法和睡眠疗法的支付变化。
哪些技术最有可能在医院和家庭中广泛应用,包括电子人工呼吸器、麻醉诱导设备、高流量鼻导管治疗、PAP 呼吸机和睡眠接口,以提高舒适度和依从性?
供应商和服务提供者应如何规划在家庭和门诊环境中发挥越来越重要的作用,包括培训、服务覆盖范围、设备便携性以及与临床医生和看护者的数据共用?
鑑于睡眠检测方式向家庭睡眠检测转变,以及需要有效地对患者进行分诊以确定是否需要进行 PAP 治疗和后续随访,睡眠诊断的前景如何?
哪些风险可能会减缓市场成长,例如报销减少、劳动力短缺、依从性障碍以及区域供应商的财务状况?
iData Research 发布的美国ARS 设备市场报告透过详细的细分和配置模型、企业市场占有率分析和定价来回答这些问题。
本报告可用于了解产品和医疗保健环境的需求,制定产品蓝图,使服务计画与医疗保健提供者的限制保持一致,并设定定价、合约和库存目标。
The U.S. anesthesia, respiratory and sleep management device market was valued at nearly $7 billion in 2024. The market is projected to grow to approach $9 billion over the forecast period.
This report covers anesthesia delivery units, anesthesia monitors, anesthesia information management systems, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices, sleep diagnostic devices, and extracorporeal membrane oxygenation (ECMO) systems.
Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.
Qualitative coverage includes market drivers and limiters, mergers and acquisitions, product portfolios, recalls where relevant, and competitive positioning across hospitals, ambulatory surgery centers, and home care.
Market Overview
Demographic shifts and technology adoption continue to shape U.S. demand for ARS devices. An aging population and rising obesity rates increase the burden of respiratory disease and sleep apnea while also lifting surgical volumes that depend on safe anesthesia care.
Health systems have modernized anesthesia delivery and monitoring fleets to work with electronic medical record systems, which changed replacement timing and procurement priorities. In respiratory and sleep therapy, many devices are moving from stationary to portable formats to support comfort, adherence, and care outside the hospital.
Vendors that combine reliable hardware with simple workflows, data connectivity, and service programs are well positioned as providers standardize across sites of care.
Market Drivers
Demographic pressure. Baby boomers represent the largest share of the U.S. population. Obesity affects an estimated 40 percent of Americans. Both trends raise the need for anesthesia during surgery and increase the number of patients who require respiratory support and sleep apnea therapy.
Shift to home and outpatient care. Portable oxygen concentrators, home ventilators, compact nebulizers, and positive airway pressure devices extend therapy into the home. Ambulatory surgical centers adopt anesthesia monitoring and information systems that fit short stay workflows.
Advancing technology. Modern anesthesia delivery units and ventilators use electronic controls for precision and ease of use. Sleep therapy and diagnostic devices add features that improve comfort and adherence. Mobile apps and remote monitoring support coaching, data sharing, and follow up.
EMR integration and automation. Hospital programs favor devices that support auto programming and auto documentation. This reinforces replacement of older anesthesia delivery units and monitors with systems that can connect to scheduling and record keeping.
Public awareness and testing. Sleep apnea awareness is rising, yet many severe cases remain undiagnosed. Policies that favor home sleep testing increase access to diagnostics and feed more patients into therapy.
Market Limiters
High capital and maintenance costs. Anesthesia delivery units, ventilators, and information systems require upfront investment and ongoing training and service. Budget limits in small hospitals and some public facilities can delay replacement.
Patient non-adherence. Long term therapy for sleep apnea and oxygen requires consistent use. Discomfort or inconvenience reduces adherence, which lowers realized demand compared with the clinical need.
GPO pricing and competitive bidding. Group purchasing organizations compress price corridors. Durable medical equipment bidding programs apply to sleep and oxygen therapy and drive reimbursement reductions, which influence device prices and provider behavior.
Reimbursement pressure. Lower payments for home oxygen and related services reduce provider margins. Policy changes have reduced the number of oxygen suppliers in some regions.
Skilled personnel shortages. Shortages of respiratory therapists, anesthesia professionals, and sleep technologists limit the pace at which services can expand, especially outside major metro areas.
Market Coverage and Data Scope
Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage. Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that affect demand.
Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.
Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.
Method note. Revenue modeling uses units multiplied by ASP, validated against installed base, utilization, and policy impacts for hospital and home settings.
Markets Covered and Segmentation
Anesthesia Delivery Unit (ADU) Market
By setting. Hospital operating room, other hospital suite, ambulatory surgery center.
Anesthesia Monitor Market
By setting. Hospital monitor, ambulatory surgery center monitor.
Anesthesia Information Management System (AIMS) Market
By setting. Hospital, ambulatory surgery center.
Anesthesia Disposables Market
By device type. Anesthesia circuit, anesthesia mask, endotracheal tube, laryngeal mask.
Ventilator Market
By device type. Acute care, sub-acute care, home care, neonatal, non-invasive, emergency transport.
Nebulizer Market
By device type. Compressor or jet, vibrating.
Respiratory Disposables Market
By device type. Oxygen cannula, oxygen mask, tracheostomy tube, resuscitator, incentive spirometer, heat and moisture exchanger.
Oxygen Therapy Market
By device type. Oxygen concentrator, transfilling device, aluminum medical oxygen cylinder, medical oxygen regulator for home care, oxygen conserver, high flow nasal therapy device.
Therapeutic Obstructive Sleep Apnea Market
By device type. Positive airway pressure devices, sleep therapy interfaces.
Sleep Diagnostic Device Market
By device type. Type I, Type II, Type III, Type IV.
Extracorporeal Membrane Oxygenation (ECMO) Market
By device type. Machine, disposable.
Competitive Analysis
ResMed led the overall ARS market in 2024 on strength in obstructive sleep apnea. The company also participates in sleep diagnostics and holds a modest share in ventilators and respiratory disposables.
Philips ranked second on the basis of anesthesia monitors. It previously led in ventilators, OSA, sleep diagnostics, and oxygen therapy, but recall actions caused an exit from those U.S. segments.
CAIRE is a leading name in oxygen concentrators with portable and transportable lines and a stationary product launch in 2025.
Other competitors participate across anesthesia, ventilation, sleep, oxygen therapy, and disposables. Portfolio fit, service networks, and data integrations are important for long term positions.
Technology and Practice Trends
Portable and user friendly devices. Concentrators and nebulizers have become lighter and simpler. PAP systems and interfaces improve comfort to support adherence.
Digitally connected anesthesia. Modern ADUs and monitors are selected based on ease of integration with EMR workflows.
Preparedness and installed base. COVID-19 raised awareness of surge capacity and infection control. While capital markets reset after the initial spike, disposables use remains above pre-pandemic levels in many programs.
Home sleep testing. Policy support for home tests expands access and brings more patients into treatment.
Care Settings
Coverage spans hospitals, ambulatory surgery centers, physician offices where relevant, and home care. Shifts in site of care affect pricing, product selection, logistics, and service models. Vendors address these differences with tailored kits, remote monitoring options, and simple patient interfaces.
Geography
This edition covers the United States.
Where is the largest and fastest growing opportunity within the U.S. anesthesia, respiratory and sleep management device market and which categories contribute most to value creation through 2031.
How does the ARS device market relate to the broader U.S. economy and to provider operations, including staffing, reimbursement, and digital transformation of clinical workflows.
What forces will shape the market going forward, including aging, obesity, outpatient migration, EMR integration, home sleep testing, and preparedness planning.
How will policy and reimbursement affect price and access, including the impact of group purchasing organizations, durable medical equipment bidding programs, and payment changes for home oxygen and sleep therapy.
Which technologies have the clearest adoption path in hospitals and at home, including electronically controlled ventilators and anesthesia delivery units, high flow nasal therapy, PAP devices, and sleep interfaces that improve comfort and adherence.
How should providers and suppliers plan for the rising role of home and ambulatory settings, including training, service coverage, device portability, and data sharing with clinicians and caregivers.
What is the outlook for sleep diagnostics, given the shift to home sleep testing and the need to triage patients efficiently for PAP therapy and follow up.
Which risks could slow market growth, including reimbursement reductions, workforce shortages, adherence barriers, and the financial condition of regional providers.
The U.S. ARS device market report from iData Research answers these questions with segment and setting models, company share analysis, and pricing detail.
Use it to size demand by product and care setting, plan product roadmaps, align service programs with provider constraints, and set targets for pricing, contracting, and inventory.